Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience

Renal denervation using the technique of radiofrequency is used only recently for the treatment of resistant hypertension. Normally, it is done under general anesthesia because the ablation point technique is painful. We suggest an alternative to general anesthesia comprising an association of morph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annales de cardiologie et d'angeiologie 2013-11, Vol.62 (5), p.283
Hauptverfasser: Pansieri, M, Barnay, P, Larderet, E, Krebs, G, Aboukhoudir, F, Andrieu, S, Cheggour, S, Faugier, J-P, Metge, M, Hirsch, J-L
Format: Artikel
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page 283
container_title Annales de cardiologie et d'angeiologie
container_volume 62
creator Pansieri, M
Barnay, P
Larderet, E
Krebs, G
Aboukhoudir, F
Andrieu, S
Cheggour, S
Faugier, J-P
Metge, M
Hirsch, J-L
description Renal denervation using the technique of radiofrequency is used only recently for the treatment of resistant hypertension. Normally, it is done under general anesthesia because the ablation point technique is painful. We suggest an alternative to general anesthesia comprising an association of morphin 0.1mg/kg IV to MEOPA (gas combining oxygen and azot protoxyd) delivered through an oxygen mask. Our series includes 12 consecutive patients treated between October 2011 and June 2013, the first five patients (group 1) have received only an hydroxizin and morphin sedation. Every five have felt the ablation painful, in two cases bearable pain (EVA5) pain leading to increasing doses of morphin, (total dose of 0.25mg/kg in two cases, 0.17mg in one case). For the seven following patients, a protocol including hydroxyzin, morphin and MEOPA given through a mask has been set up. Only one patient has felt a mild pain (EVA 5) leading to an increasing dose of morphin (total dose 0.17mg/kg). None of the six other patients has felt any pain during the procedure. The average dose of morphin is 0.17mg/kg in group 1, 0.11mg/kg in group 2. This is a preliminary study; if confirmed, it will allow a lot of hospitals without on-site possibilities of general anesthesia, to realize such procedures. regarding pain, the procedure of renal ablation was well tolerated for six among seven patients receiving the association MEOPA and IV morphin. In contrast, in the five patients treated only with IV morphin, we observed a less good tolerance to pain and the need to increase the doses of IV morphin.
doi_str_mv 10.1016/j.ancard.2013.08.020
format Article
fullrecord <record><control><sourceid>hal_pubme</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01333858v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_HAL_hal_01333858v1</sourcerecordid><originalsourceid>FETCH-LOGICAL-h904-8ef7a5419a456c7564d81d309d04899f6a2b916d31553ad98d87b009a0a3db863</originalsourceid><addsrcrecordid>eNo90FFLwzAQB_Agihtz30Akrz60Xpo2TXwbQ50w2ZC9j-uSrpEuKWk33Sfwa9sx9eng7nfH8SfklkHMgImHjxjdBoOOE2A8BhlDAhdkyHIhI84kuyRDAOARV4kckHHb2gKYEkmeM3FNBkkKAlKRDsn3u3FYU22cCQfsrHe09IEG09q2Q9fR6tiY0BnXnkaftqv8vqPbE-_X0Jm2q3qLjxT1ofe4NdSXFOnb02I5oTsfmso6Q5vgO7_xdUyXwdR2Zx2GIzVf_XFr3MbckKsS69aMf-uIrJ6fVtNZNF-8vE4n86hSkEbSlDlmKVOYZmKTZyLVkmkOSkMqlSoFJoViQnOWZRy1klrmBYBCQK4LKfiI3J_PVlivm2B3_Rdrj3Y9m8zXp14fJ-cykwfW27uzbfbFzuh__hce_wGVenWF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Pansieri, M ; Barnay, P ; Larderet, E ; Krebs, G ; Aboukhoudir, F ; Andrieu, S ; Cheggour, S ; Faugier, J-P ; Metge, M ; Hirsch, J-L</creator><creatorcontrib>Pansieri, M ; Barnay, P ; Larderet, E ; Krebs, G ; Aboukhoudir, F ; Andrieu, S ; Cheggour, S ; Faugier, J-P ; Metge, M ; Hirsch, J-L</creatorcontrib><description>Renal denervation using the technique of radiofrequency is used only recently for the treatment of resistant hypertension. Normally, it is done under general anesthesia because the ablation point technique is painful. We suggest an alternative to general anesthesia comprising an association of morphin 0.1mg/kg IV to MEOPA (gas combining oxygen and azot protoxyd) delivered through an oxygen mask. Our series includes 12 consecutive patients treated between October 2011 and June 2013, the first five patients (group 1) have received only an hydroxizin and morphin sedation. Every five have felt the ablation painful, in two cases bearable pain (EVA&lt;5), in three cases intense (EVA&gt;5) pain leading to increasing doses of morphin, (total dose of 0.25mg/kg in two cases, 0.17mg in one case). For the seven following patients, a protocol including hydroxyzin, morphin and MEOPA given through a mask has been set up. Only one patient has felt a mild pain (EVA 5) leading to an increasing dose of morphin (total dose 0.17mg/kg). None of the six other patients has felt any pain during the procedure. The average dose of morphin is 0.17mg/kg in group 1, 0.11mg/kg in group 2. This is a preliminary study; if confirmed, it will allow a lot of hospitals without on-site possibilities of general anesthesia, to realize such procedures. regarding pain, the procedure of renal ablation was well tolerated for six among seven patients receiving the association MEOPA and IV morphin. In contrast, in the five patients treated only with IV morphin, we observed a less good tolerance to pain and the need to increase the doses of IV morphin.</description><identifier>ISSN: 0003-3928</identifier><identifier>EISSN: 1768-3181</identifier><identifier>DOI: 10.1016/j.ancard.2013.08.020</identifier><identifier>PMID: 24060464</identifier><language>eng ; fre</language><publisher>France: Elsevier Masson</publisher><subject><![CDATA[Aged ; Analgesics, Non-Narcotic - administration & dosage ; Analgesics, Opioid - administration & dosage ; Catheter Ablation - adverse effects ; Catheter Ablation - methods ; Denervation - methods ; Drug Combinations ; Female ; Humans ; Hypertension - surgery ; Life Sciences ; Male ; Middle Aged ; Morphine - administration & dosage ; Nitrous Oxide - administration & dosage ; Oxygen Compounds - administration & dosage ; Pain - etiology ; Pain - prevention & control ; Pain Measurement ; Renal Artery - surgery]]></subject><ispartof>Annales de cardiologie et d'angeiologie, 2013-11, Vol.62 (5), p.283</ispartof><rights>Copyright © 2013. Published by Elsevier SAS.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-1142-770X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24060464$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01333858$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Pansieri, M</creatorcontrib><creatorcontrib>Barnay, P</creatorcontrib><creatorcontrib>Larderet, E</creatorcontrib><creatorcontrib>Krebs, G</creatorcontrib><creatorcontrib>Aboukhoudir, F</creatorcontrib><creatorcontrib>Andrieu, S</creatorcontrib><creatorcontrib>Cheggour, S</creatorcontrib><creatorcontrib>Faugier, J-P</creatorcontrib><creatorcontrib>Metge, M</creatorcontrib><creatorcontrib>Hirsch, J-L</creatorcontrib><title>Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience</title><title>Annales de cardiologie et d'angeiologie</title><addtitle>Ann Cardiol Angeiol (Paris)</addtitle><description>Renal denervation using the technique of radiofrequency is used only recently for the treatment of resistant hypertension. Normally, it is done under general anesthesia because the ablation point technique is painful. We suggest an alternative to general anesthesia comprising an association of morphin 0.1mg/kg IV to MEOPA (gas combining oxygen and azot protoxyd) delivered through an oxygen mask. Our series includes 12 consecutive patients treated between October 2011 and June 2013, the first five patients (group 1) have received only an hydroxizin and morphin sedation. Every five have felt the ablation painful, in two cases bearable pain (EVA&lt;5), in three cases intense (EVA&gt;5) pain leading to increasing doses of morphin, (total dose of 0.25mg/kg in two cases, 0.17mg in one case). For the seven following patients, a protocol including hydroxyzin, morphin and MEOPA given through a mask has been set up. Only one patient has felt a mild pain (EVA 5) leading to an increasing dose of morphin (total dose 0.17mg/kg). None of the six other patients has felt any pain during the procedure. The average dose of morphin is 0.17mg/kg in group 1, 0.11mg/kg in group 2. This is a preliminary study; if confirmed, it will allow a lot of hospitals without on-site possibilities of general anesthesia, to realize such procedures. regarding pain, the procedure of renal ablation was well tolerated for six among seven patients receiving the association MEOPA and IV morphin. In contrast, in the five patients treated only with IV morphin, we observed a less good tolerance to pain and the need to increase the doses of IV morphin.</description><subject>Aged</subject><subject>Analgesics, Non-Narcotic - administration &amp; dosage</subject><subject>Analgesics, Opioid - administration &amp; dosage</subject><subject>Catheter Ablation - adverse effects</subject><subject>Catheter Ablation - methods</subject><subject>Denervation - methods</subject><subject>Drug Combinations</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - surgery</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Morphine - administration &amp; dosage</subject><subject>Nitrous Oxide - administration &amp; dosage</subject><subject>Oxygen Compounds - administration &amp; dosage</subject><subject>Pain - etiology</subject><subject>Pain - prevention &amp; control</subject><subject>Pain Measurement</subject><subject>Renal Artery - surgery</subject><issn>0003-3928</issn><issn>1768-3181</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90FFLwzAQB_Agihtz30Akrz60Xpo2TXwbQ50w2ZC9j-uSrpEuKWk33Sfwa9sx9eng7nfH8SfklkHMgImHjxjdBoOOE2A8BhlDAhdkyHIhI84kuyRDAOARV4kckHHb2gKYEkmeM3FNBkkKAlKRDsn3u3FYU22cCQfsrHe09IEG09q2Q9fR6tiY0BnXnkaftqv8vqPbE-_X0Jm2q3qLjxT1ofe4NdSXFOnb02I5oTsfmso6Q5vgO7_xdUyXwdR2Zx2GIzVf_XFr3MbckKsS69aMf-uIrJ6fVtNZNF-8vE4n86hSkEbSlDlmKVOYZmKTZyLVkmkOSkMqlSoFJoViQnOWZRy1klrmBYBCQK4LKfiI3J_PVlivm2B3_Rdrj3Y9m8zXp14fJ-cykwfW27uzbfbFzuh__hce_wGVenWF</recordid><startdate>201311</startdate><enddate>201311</enddate><creator>Pansieri, M</creator><creator>Barnay, P</creator><creator>Larderet, E</creator><creator>Krebs, G</creator><creator>Aboukhoudir, F</creator><creator>Andrieu, S</creator><creator>Cheggour, S</creator><creator>Faugier, J-P</creator><creator>Metge, M</creator><creator>Hirsch, J-L</creator><general>Elsevier Masson</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-1142-770X</orcidid></search><sort><creationdate>201311</creationdate><title>Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience</title><author>Pansieri, M ; Barnay, P ; Larderet, E ; Krebs, G ; Aboukhoudir, F ; Andrieu, S ; Cheggour, S ; Faugier, J-P ; Metge, M ; Hirsch, J-L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h904-8ef7a5419a456c7564d81d309d04899f6a2b916d31553ad98d87b009a0a3db863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; fre</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Analgesics, Non-Narcotic - administration &amp; dosage</topic><topic>Analgesics, Opioid - administration &amp; dosage</topic><topic>Catheter Ablation - adverse effects</topic><topic>Catheter Ablation - methods</topic><topic>Denervation - methods</topic><topic>Drug Combinations</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - surgery</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Morphine - administration &amp; dosage</topic><topic>Nitrous Oxide - administration &amp; dosage</topic><topic>Oxygen Compounds - administration &amp; dosage</topic><topic>Pain - etiology</topic><topic>Pain - prevention &amp; control</topic><topic>Pain Measurement</topic><topic>Renal Artery - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pansieri, M</creatorcontrib><creatorcontrib>Barnay, P</creatorcontrib><creatorcontrib>Larderet, E</creatorcontrib><creatorcontrib>Krebs, G</creatorcontrib><creatorcontrib>Aboukhoudir, F</creatorcontrib><creatorcontrib>Andrieu, S</creatorcontrib><creatorcontrib>Cheggour, S</creatorcontrib><creatorcontrib>Faugier, J-P</creatorcontrib><creatorcontrib>Metge, M</creatorcontrib><creatorcontrib>Hirsch, J-L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Annales de cardiologie et d'angeiologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pansieri, M</au><au>Barnay, P</au><au>Larderet, E</au><au>Krebs, G</au><au>Aboukhoudir, F</au><au>Andrieu, S</au><au>Cheggour, S</au><au>Faugier, J-P</au><au>Metge, M</au><au>Hirsch, J-L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience</atitle><jtitle>Annales de cardiologie et d'angeiologie</jtitle><addtitle>Ann Cardiol Angeiol (Paris)</addtitle><date>2013-11</date><risdate>2013</risdate><volume>62</volume><issue>5</issue><spage>283</spage><pages>283-</pages><issn>0003-3928</issn><eissn>1768-3181</eissn><abstract>Renal denervation using the technique of radiofrequency is used only recently for the treatment of resistant hypertension. Normally, it is done under general anesthesia because the ablation point technique is painful. We suggest an alternative to general anesthesia comprising an association of morphin 0.1mg/kg IV to MEOPA (gas combining oxygen and azot protoxyd) delivered through an oxygen mask. Our series includes 12 consecutive patients treated between October 2011 and June 2013, the first five patients (group 1) have received only an hydroxizin and morphin sedation. Every five have felt the ablation painful, in two cases bearable pain (EVA&lt;5), in three cases intense (EVA&gt;5) pain leading to increasing doses of morphin, (total dose of 0.25mg/kg in two cases, 0.17mg in one case). For the seven following patients, a protocol including hydroxyzin, morphin and MEOPA given through a mask has been set up. Only one patient has felt a mild pain (EVA 5) leading to an increasing dose of morphin (total dose 0.17mg/kg). None of the six other patients has felt any pain during the procedure. The average dose of morphin is 0.17mg/kg in group 1, 0.11mg/kg in group 2. This is a preliminary study; if confirmed, it will allow a lot of hospitals without on-site possibilities of general anesthesia, to realize such procedures. regarding pain, the procedure of renal ablation was well tolerated for six among seven patients receiving the association MEOPA and IV morphin. In contrast, in the five patients treated only with IV morphin, we observed a less good tolerance to pain and the need to increase the doses of IV morphin.</abstract><cop>France</cop><pub>Elsevier Masson</pub><pmid>24060464</pmid><doi>10.1016/j.ancard.2013.08.020</doi><orcidid>https://orcid.org/0000-0002-1142-770X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0003-3928
ispartof Annales de cardiologie et d'angeiologie, 2013-11, Vol.62 (5), p.283
issn 0003-3928
1768-3181
language eng ; fre
recordid cdi_hal_primary_oai_HAL_hal_01333858v1
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Aged
Analgesics, Non-Narcotic - administration & dosage
Analgesics, Opioid - administration & dosage
Catheter Ablation - adverse effects
Catheter Ablation - methods
Denervation - methods
Drug Combinations
Female
Humans
Hypertension - surgery
Life Sciences
Male
Middle Aged
Morphine - administration & dosage
Nitrous Oxide - administration & dosage
Oxygen Compounds - administration & dosage
Pain - etiology
Pain - prevention & control
Pain Measurement
Renal Artery - surgery
title Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T03%3A24%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hal_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Renal%20denervation%20for%20resistant%20hypertension%20without%20general%20anesthesia:%20advantage%20of%20a%20MEOPA%20morphine%20protocol.%20Preliminary%20experience&rft.jtitle=Annales%20de%20cardiologie%20et%20d'angeiologie&rft.au=Pansieri,%20M&rft.date=2013-11&rft.volume=62&rft.issue=5&rft.spage=283&rft.pages=283-&rft.issn=0003-3928&rft.eissn=1768-3181&rft_id=info:doi/10.1016/j.ancard.2013.08.020&rft_dat=%3Chal_pubme%3Eoai_HAL_hal_01333858v1%3C/hal_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24060464&rfr_iscdi=true